Commentary (Research Highlights: Targeted Inhibition of miR-155 Promotes Post-Stroke Neovascularization and Functional Recovery)

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|15|4|372-374

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.15, Iss.4, 2016-05, pp. : 372-374

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Commentary [ Research Highlights(To miR or Not to miR: That is the Question in ALS Disease ]

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 6, 2011-09 ,pp. : 648-649

Bentham Science Publishers

Access to resources Recommend Favorite

Commentary: (Research Highlights: “MiRNAcles” in Brain)

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 6, 2013-09 ,pp. : 717-718

Bentham Science Publishers

Access to resources Recommend Favorite

Serum miR‐146a, miR‐155, and miR‐210 as potential markers of Graves’ disease

By  

Journal Of Clinical Laboratory Analysis (Electronic), Vol. 32, Iss. 2, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Therapeutic Potential of Amphetamines in Post-stroke Recovery

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 3, Iss. 1, 2003-03 ,pp. : 49-55

Bentham Science Publishers

Access to resources Recommend Favorite

Commentary (Research Highlights)

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 1, 2011-02 ,pp. : 1-1

Bentham Science Publishers

Access to resources Recommend Favorite